Country profiles +
24 July 2014
The tide is about to turn in Japanese biotechnology-related patent activities, argues Henry Koda of DLA Piper Tokyo Partners readmore

06 February 2014
In 2013, the Australian High Court considered the patentability of methods of medical treatments in the Apotex v Sanofi-Aventis case readmore

23 January 2014
Supplementary protection certificates have been under discussion in Europe. Cesare Galli of IP Law Galli provides the Italian perspective on the key areas readmore

09 January 2014
Russia’s evolving IP system is helping the country to attract foreign investors readmore

South Africa
28 November 2013
Until now, a lack of information on sport supplement labels posed serious health risks, say Bryce Matthewson and Dirk Hanekom of Spoor & Fisher readmore

14 November 2013
A judicially engineered utility doctrine requires filers in Canada to prove the promise of their patents, but a trade agreement may lift other burdens. IPPro investigates readmore

FIRST << 1 2 3 4 5 >> LAST

FaceBook LinkedIn RSS feed Blog Instagram Twitter
Specialist features +
Interviews ++
Latest news +++
Matters of import
20 January 2016
Alireza Behrooz of Merchant & Gould and Nick Phillips of Edwin Coe discuss parallel importation of pharmaceuticals in the US and Europe readmore

Raising the bar
16 December 2015
Amendments to the US Civil Rules of Procedure could dissuade some non-practicing entities from targeting technology-rich sectors readmore

Making connections
02 December 2015
Changes are coming to the UK Patent Box to meet new international standards readmore

More features
Terry Mahn
Fish & Richardson
03 February 2016
Terry Mahn of Fish & Richardson discusses the issues still to be resolved in the Food and Drug Administration’s proposed naming system for biosimilars readmore

Rogelio Nicandro
Romulo LLP
04 November 2015
Rogelio Nicandro of Romulo LLP offers some handy tips for stopping trademark infringement in the Philippines readmore

Grant Shoebridge
Shelston IP
04 November 2015
Grant Shoebridge of Shelston IP unpacks the Australian High Court’s Myriad decision readmore

More interviews
AstraZeneca enters China with Plendil
02 March 2016 | London
AstraZeneca has entered into a licensing agreement with China Medical System (CMS) Holdings for the commercialisation rights in China to its calcium channel blocker, Plendil (felodipine)... readmore

Hogan Lovells boosts capabilities in Japan
01 March 2016 | Tokyo
Hogan Lovells has boosted its Japanese domestic patent capability with the hire of Hiroto Imai... readmore

Morgan Lewis bags four from K&L Gates
29 February 2016 | Chicago
Morgan Lewis has expanded its global IP team with four new partners from K&L Gates... readmore

More news

IPPro Life Sciences


Copyright (C) 2013 Black Knight Media Ltd. All rights reserved. No reproduction without prior authorization